Fundraising Fox
/Companies
Sign in

Nanocrine

Frederick, US · 2 known investors

Find your way into Nanocrine

Sign up to see every warm intro you have to Nanocrine

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanocrine team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.

BiotechDeep TechHardware

Founders & leadership

STSteve Turner
Steve TurnerCo-Founder, Chairman
JBJim Bailey
Jim BaileyCo-founder; Director; Business Advisor
PJPatrick J. Calhoun
Patrick J. CalhounPresident & Chief Science OfficerPatrick J. Calhoun served in the U.S. Army from 2007 to 2012 and subsequently earned a B.S. in microbiology and Ph.D. in cell and molecular biology from Virginia Tech, followed by postdoctoral training in molecular cardiology at Johns Hopkins School of Medicine. As President and Chief Science Officer of Nanocrine, he has led the company's development of nanoplasmonic biosensor technology for real-time protein secretion imaging in cell biology research.
KWKen Wolf
Ken WolfChief Communications Director

Investors · 2

TEDCOlisted by TEDCOColumbia

Related companies · 3

Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
AgilentAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).

Companies working in the same space as Nanocrine.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2020$248.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Nanocrine do?
Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.
Who founded Nanocrine?
Nanocrine was founded by Steve Turner, Jim Bailey.
Who are Nanocrine's investors?
Nanocrine's investors include Maryland TEDCO, TEDCO.
Where is Nanocrine headquartered?
Nanocrine is headquartered in Frederick, US.